Skip to page content

Seattle biotech doubles space with new lease in Interbay


The Labs
Curi Bio will lease its new Interbay space from BioMed Realty.
Benjamin Benschneider

Seattle-based biotech company Curi Bio has signed a lease with BioMed Realty with plans to relocate to a 13,942-square-foot space in Interbay.

The biotech occupies roughly 6,000 square feet at 3000 Western Ave. now, according to Eric Swanson, Curi Bio's vice president of operations. It is still finalizing its moving plans for the new space at 201 Elliott Ave. W, but Swanson said the goal is to move during the first quarter of 2025.

"We wanted some more room to expand," Swanson said. "It gives us room to grow our operations and grow some of our research efforts and grow our team a little bit over the years."

BioMed Realty markets the building as The Labs at 201 Elliott. The building is also the headquarters of the biopharmaceutical company Omeros. The five-story building has 151,194 square feet.


Related coverage

"We have tissue culture labs for our biologists to be working on our novel human stem cell-derived tissue models," Swanson said. "We also have space for engineers to develop our biosystems that measure those tissues we're building, as well as space for manufacturing."

Swanson said Curi Bio has been at its current 3000 Western Ave. space for about four years.

Washington Holdings in May of last year unveiled plans to acquire the property and replace it with an apartment building. Officials said at the time acquisition and construction wouldn't happen until 2025 at the earliest.

Swanson said the eventual goal is to double the company's headcount, including adding to its commercial team, though he didn't provide a current employment figure. The headcount growth will be a mix of in Seattle and elsewhere, as Curi Bio aims to set up hubs in other regions to support customers. The company's clients include pharmaceutical and biotech companies around the world.

Curi Bio, founded in 2015, makes stem cell-based tissue models and data analysis tools for drug discovery. That includes skeletal muscle models, cardiac models and disease models.


For more stories like this one, sign up for Seattle Inno newsletters from the Puget Sound Business Journal and the American Inno network.


Keep Digging



SpotlightMore

Nancy Xiao (left) and Jim Xiao (right) are swapping roles at Seattle-based Mason.
See More
SPOTLIGHT Awards
See More
Image via Getty
See More
Image via Getty Images
See More

Upcoming Events More

Oct
03
TBJ
Oct
17
TBJ

Want to stay ahead of who & what is next? Sent weekly, the Beat is your definitive look at Seattle’s innovation economy, offering news, analysis & more on the people, companies & ideas driving your region forward. Follow the Beat.

Sign Up